Cynata Therapeutics jumps as FDA OK’s stem cell rejection treatment
Cynata Therapeutics (ASX:CYP) share price up 8% as FDA awards major US approval for trial
Thu 26 May 22, 12:46pm (AEST)
Stock prices will auto-update without reloading the page. How it works:
More about Cboe Live pricing.
Cynata Therapeutics (ASX:CYP) share price up 8% as FDA awards major US approval for trial
Other Markets News